Data completeness
2/8 — Basic
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TAO (troleandomycin) is an oral macrolide antibiotic in suspension formulation currently in pre-launch development by Pfizer. Mechanism of action and specific indications are not yet disclosed in this profile. The drug represents a small-molecule antibacterial candidate.
Pre-Launch
Pre-launch stage offers limited commercial trajectory data; team size and resource allocation dependent on internal Pfizer prioritization and regulatory outcomes.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
ROTAO 1 - Feasibility and Safety of the TAVIPILOT Tele-operated Robot During Transcatheter Aortic Valve Replacement (TAVR/TAVI)
Started Sep 2025
10 enrolled
TAVI(Transcatheter Aortic Valve Implantation)
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Started Nov 2020
540 enrolled
Ovarian Neoplasm EpithelialFallopian Tube NeoplasmsPeritoneal Neoplasms+3 more
TAO Outpatient Trial for Anxiety and Depression
Started Jan 2018
300 enrolled
Anxiety DisordersDepression
TruFreeze™ Airway Obstruction: TAO STUDY
Started Jul 2013
0Lung Disease AirwaysLung Diseases, ObstructiveAirway; Obstruction, With Emphysema+1 more
Worked on TAO at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.